In conjunction with SCA’s acquisition of Georgia-Pacific’s European tissue
operations during the summer of 2012, the EU Commission imposed requirements
concerning the divestment of certain units within consumer tissue. This was
communicated in a press release on July 19, 2012. The EU Commission has now
approved the divestments.
The requirements imposed by the EU Commission included the sale of parts of
Georgia-Pacific’s former operations in the UK, Ireland and the Benelux
countries, and certain operations in the Scandinavian region.
The branded business in the UK, Ireland and the Benelux countries is being sold
to Sofidel. The production facility in Horwich, UK, is included in this
transaction.
The retailer brand businesses in the UK and Ireland are being sold to Northwood
& WEPA. The production facility in Bridgend, UK, is included in this
transaction.
Parts of the Nordic retailer brand business have been sold to Vajda Papir. The
production facility in Drammen, Norway is included in the transaction, together
with a conversion line from the facility in Nokia, Finland.
These operations together represent total sales of about EUR 200m and the
combined purchase consideration is approximately EUR 100m.
SCA is a leading global hygiene and forest products company. The Group develops
and produces sustainable personal care, tissue and forest products. Sales are
conducted in about 100 countries under
many strong brands, including the leading global brands TENA and Tork, and
regional brands, such as Lotus, Libresse, Tempo and Libero. As Europe’s largest
private forest owner, SCA places considerable emphasis
on sustainable forest management. The Group has about 36,000 employees and sales
in 2012 amounted
to SEK 85bn (EUR 9.8bn). SCA was founded in 1929, has its headquarters in
Stockholm, Sweden, and
is listed on NASDAQ OMX Stockholm. For more information, visit www.sca.com.
